Global Markets for Treatment and Diagnosis of Sexually Transmitted Diseases
The global market for treatment and diagnosis of sexually transmitted diseases was valued at $28.2 billion in 2011 and $33.2 billion in 2012. Total market value is expected to reach nearly $52 billion in 2017 after increasing at a five-year compound annual growth rate of 9.3%.
- An overview of the markets for the diagnoses of and treatments for sexually transmitted diseases, including bacterial vaginosis, candidiasis, chancroid, chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, HIV/AIDS, pediculosis pubis, syphilis, and trichomoniasis.
- Analyses of global market trends, with data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017.
- Identifications of common STDs, citing risk factors, incidence, and mortality for each.
- Discussion of products on the market.
- A list of current and potential competitors in the market and their market shares.
- Comprehensive company profiles of major players in the industry.
This market report organizes information from diverse sources into a cohesive report that includes a disease overview, industry structure, diagnostic products, pharmaceutical products, emerging technology, regulations by region and patents sections.
Peggy S. Lehr holds a Bachelor of Science degree in Journalism from the University of Colorado, Boulder, and a Master of Special Studies degree in Communication from the University of Denver. Ms. Lehr has worked as a researcher, editor and publisher within the publishing industry for both for-profit and not-for-profit organizations.